Latest filing published 04 Aug 2014 for Phio Pharmaceuticals Corp., €741.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -83.8%Entry US$1,485,000.00 · Close at T+365 US$239,976.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Advanced RNA Technologies, LLC: trading record in brief
All filings by Advanced RNA Technologies, LLC on record concern Phio Pharmaceuticals Corp. Over a trading history stretching from 5 February 2013 to 31 July 2014, the count stands at 91 filings.
The open-market record is one-sided, with 1 purchase worth €741 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2014 alone, the filings show 1 purchase and no sales.
On 4 August 2014 came the latest disclosure, an open-market purchase for €741 in Phio Pharmaceuticals Corp. Typically, a trade is published a median of 14 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Advanced RNA Technologies, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400 shares@ US$2.48Common Stock, $0.0001 par valueSEC:0001572407-14-000006:0Canonical exit: 29 Oct 2014 (T+90)
- 5,000 shares@ US$4.11Common Stock, $0.0001 par valueSEC:0001572407-14-000005:0
- 2,000 shares@ US$6.00Common Stock, $0.0001 par valueSEC:0001572407-14-000004:0
- 100 shares@ US$6.11Common Stock, $0.0001 par valueSEC:0001572407-14-000004:1
- 500 shares@ US$6.10Common Stock, $0.0001 par valueSEC:0001572407-14-000004:2
- 1,400 shares@ US$6.10Common Stock, $0.0001 par valueSEC:0001572407-14-000004:3
- 59 shares@ US$5.55Common Stock, $0.0001 par valueSEC:0001572407-14-000004:4
- 1,000 shares@ US$5.61Common Stock, $0.0001 par valueSEC:0001572407-14-000004:5
- 1,000 shares@ US$5.70Common Stock, $0.0001 par valueSEC:0001572407-14-000004:6
- 1,941 shares@ US$5.55Common Stock, $0.0001 par valueSEC:0001572407-14-000004:7
- 2,000 shares@ US$6.00Common Stock, $0.0001 par valueSEC:0001572407-14-000004:8
- 5,000 shares@ US$6.00Common Stock, $0.0001 par valueSEC:0001572407-14-000002:0
- 5,000 shares@ US$6.55Common Stock, $0.0001 par valueSEC:0001572407-14-000002:1
- 400 shares@ US$6.03Common Stock, $0.0001 par valueSEC:0001572407-14-000002:2
- 5,000 shares@ US$6.45Common Stock, $0.0001 par valueSEC:0001572407-14-000002:3
- 1,300 shares@ US$6.11Common Stock, $0.0001 par valueSEC:0001572407-14-000002:4
- 400 shares@ US$6.10Common Stock, $0.0001 par valueSEC:0001572407-14-000002:5
- 2,600 shares@ US$6.20Common Stock, $0.0001 par valueSEC:0001572407-14-000002:6
- 5,000 shares@ US$6.15Common Stock, $0.0001 par valueSEC:0001572407-14-000002:7
- 2,000 shares@ US$5.91Common Stock, $0.0001 par valueSEC:0001572407-14-000002:8
- 2,000 shares@ US$5.80Common Stock, $0.0001 par valueSEC:0001572407-14-000002:9
- 1,200 shares@ US$4.70Common Stock, $0.0001 par valueSEC:0001572407-14-000001:0
- 5,641 shares@ US$4.75Common Stock, $0.0001 par valueSEC:0001572407-14-000001:1
- 2,900 shares@ US$4.74Common Stock, $0.0001 par valueSEC:0001572407-14-000001:2
- 2,100 shares@ US$4.71Common Stock, $0.0001 par valueSEC:0001572407-14-000001:3
25 of 88 declarations
